Table 1.

Demographics of 107 WT1 negative EnOCs.

		N	%/range
Age at diagnosis	Median years	57	28–88
Body mass index	Median	25.5	18.0–44.0
Disease grade	G1 EnOC	80	74.7
	G2 EnOC	19	17.8
	G3 EnOC	8	7.5
FIGO stage at diagnosis	I	47	44.8
	II	42	40.0
	III	10	9.5
	IV	6	5.7
	NA	2
RD following debulking	<2 cma	93	90.3
	≥2 cm	10	9.7
	NA	4
p53 IHC pattern	AP	11	10.5
	AN	0	0.0
	WT	94	89.5
	NE	2

EnOC, endometrioid ovarian carcinoma; NA, not available; RD, residual disease; IHC, immunohistochemistry; AP, aberrant diffuse nuclear positive; AN, aberrant null; WT, wild-type; NE, not evaluable.

^aDue to the retrospective nature of this cohort and the historic classification of <2 cm residual disease as optimal debulking, debulking status is not resolved beyond <2 cm in this cohort.